In 2023, Brii Biosciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Brii Biosciences has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Brii Biosciences amounted to 68.67 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2021, the total operational greenhouse gas (GHG) emissions of Brii Biosciences decreased by 45.34%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2023, the total Scope 1 emissions of Brii Biosciences were 0 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
In 2023, Brii Biosciences reported Scope 2 greenhouse gas (GHG) emissions of 68.67 tCOâ‚‚e without specifying the calculation method.
Compared to the previous year (2021), Brii Biosciences's Scope 2 emissions (Unspecified Calculation Method) fell by 45.34% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
In 2023, Brii Biosciences reported its Scope 2 emissions using an unspecified methodology.